 |
|
Evidence-Based, Cost-effective Risk Stratification and Management After Myocardial Infarction
Prakash C. Deedwania, MD;
Ezra A. Amsterdam, MD;
Randall H. Vagelos, MD
Arch Intern Med. 1997;157(3):273-280.
Abstract
| |
Current management of patients after an acute myocardial infarction (AMI) reflects a variety of approaches ranging from conservative to aggressive. Although each method is appropriate in certain subgroups, their application frequently lacks a scientific basis. Current, clinically relevant, evidence-based practice guidelines are needed for secondary prevention for survivors after an AMI. To meet this need, the California Cardiology Working Group was assembled to evaluate the available data from clinical trials and other published studies and develop evidence-based, cost-effective guidelines for clinicians to use as a basis for patient management after an AMI. The group consisted of 18 members, including cardiologists from academic institutions and physicians working in cardiac intensive care, private practices, and managed care settings, representing a broad spectrum of expertise pertaining to patients who have had an AMI. The members had expertise in cardiac intensive care, interventional cardiology, nuclear cardiology, lipid disorders, echocardiography, and cardiac rehabilitation. The intended audience for these practice guidelines includes all physicians who treat survivors of MI. A literature review of all relevant clinical trials and other published data about the natural history after AMI and the effects of current therapeutic modalities are discussed herein. Case histories served as models for application of the literature-based data. The recommendations for management were reached by consensus vote based on the scientific evidence. When more than 1 management option applied, this was recognized in the recommendations. The recommendations accompany the text.
Arch Intern Med. 1997;157:273-280
Author Affiliations
for the California Cardiology Working Group on Post-MI Management
From the Schools of Medicine, University of California, San Francisco (Dr Deedwania) and the University of California, Davis (Dr Amsterdam); and the Cardiovascular Medicine Division, Stanford University Medical Center, Palo Alto, Calif (Dr Vagelos). A list of the members of the California Cardiology Working Group appears in a box on page 274.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Physical Activity and Mortality in Older Men With Diagnosed Coronary Heart Disease
Wannamethee et al.
Circulation 2000;102:1358-1363.
ABSTRACT
| FULL TEXT
Coronary disease: Acute coronary syndromes: risk stratification
Timmis
Heart 2000;83:241-246.
FULL TEXT
Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
Brunner-La Rocca et al.
J Am Coll Cardiol 1999;33:1163-1173.
ABSTRACT
| FULL TEXT
Nonsustained Ventricular Tachycardia in the Setting of Acute Myocardial Infarction : Tachycardia Characteristics and Their Prognostic Implications
Cheema et al.
Circulation 1998;98:2030-2036.
ABSTRACT
| FULL TEXT
Underutilization of Evidence-Based Therapy in Heart Failure: An Opportunity to Deal a Winning Hand With Ace up Your Sleeve
Deedwania
Arch Intern Med 1997;157:2409-2412.
ABSTRACT
|
